Ronald Doku, Nana Yaw A Osafo, John Kwagyan, William M Southerland
{"title":"LDL-C equation disagreement as a threshold-integrity flag for orthogonal lipid confirmation.","authors":"Ronald Doku, Nana Yaw A Osafo, John Kwagyan, William M Southerland","doi":"10.1016/j.jacl.2026.09.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple low-density lipoprotein cholesterol (LDL-C) equations can be applied to every standard lipid panel. Disagreement across a treatment threshold may indicate unstable classification.</p><p><strong>Objective: </strong>To test LDL-C equation disagreement as a calculation-only threshold-integrity flag and as a trigger for orthogonal lipid confirmation.</p><p><strong>Methods: </strong>We analyzed decontaminated All of Us lipid panels with same-day standard lipids and direct homogeneous LDL-C, recognizing that direct LDL-C is a clinical reference assay rather than beta-quantification. Friedewald, Sampson/National Institutes of Health (NIH), and Martin-Hopkins were evaluated at LDL-C thresholds of 70, 100, and 130 mg/dL; 55 mg/dL was added in the temporal audit. The 3-equation disagreement flag was compared against triglyceride (TG)-based reflex rules. Medical Information Mart for Intensive Care IV (MIMIC-IV) was used for external stress testing.</p><p><strong>Results: </strong>Equation agreement identified a high-stability majority: in the primary All of Us cohort, equations agreed for 86% to 92% of panels with 92% to 95% threshold accuracy. In the temporal audit, future clean panels showed 3-equation disagreement in 10.2%, 11.4%, 9.2%, and 5.8% of rows at LDL-C thresholds of 55, 70, 100, and 130 mg/dL. Disagreement-subgroup accuracy was lower for all 3 equations. The 3-equation straddle outperformed TG ≥200 mg/dL for detecting apparent at-goal discordance at all 4 thresholds. Sparse apolipoprotein B (ApoB) analyses supported ApoB as an independent witness.</p><p><strong>Conclusion: </strong>LDL-C equation disagreement is a threshold-integrity flag, not proof that any equation is wrong. When equations disagree near a treatment goal, clinicians should avoid treating the LDL-C threshold result as unqualified and consider orthogonal confirmation, preferably ApoB, when particle burden is the clinical question.</p>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":" ","pages":""},"PeriodicalIF":6.9000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13624396/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacl.2026.09.004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multiple low-density lipoprotein cholesterol (LDL-C) equations can be applied to every standard lipid panel. Disagreement across a treatment threshold may indicate unstable classification.
Objective: To test LDL-C equation disagreement as a calculation-only threshold-integrity flag and as a trigger for orthogonal lipid confirmation.
Methods: We analyzed decontaminated All of Us lipid panels with same-day standard lipids and direct homogeneous LDL-C, recognizing that direct LDL-C is a clinical reference assay rather than beta-quantification. Friedewald, Sampson/National Institutes of Health (NIH), and Martin-Hopkins were evaluated at LDL-C thresholds of 70, 100, and 130 mg/dL; 55 mg/dL was added in the temporal audit. The 3-equation disagreement flag was compared against triglyceride (TG)-based reflex rules. Medical Information Mart for Intensive Care IV (MIMIC-IV) was used for external stress testing.
Results: Equation agreement identified a high-stability majority: in the primary All of Us cohort, equations agreed for 86% to 92% of panels with 92% to 95% threshold accuracy. In the temporal audit, future clean panels showed 3-equation disagreement in 10.2%, 11.4%, 9.2%, and 5.8% of rows at LDL-C thresholds of 55, 70, 100, and 130 mg/dL. Disagreement-subgroup accuracy was lower for all 3 equations. The 3-equation straddle outperformed TG ≥200 mg/dL for detecting apparent at-goal discordance at all 4 thresholds. Sparse apolipoprotein B (ApoB) analyses supported ApoB as an independent witness.
Conclusion: LDL-C equation disagreement is a threshold-integrity flag, not proof that any equation is wrong. When equations disagree near a treatment goal, clinicians should avoid treating the LDL-C threshold result as unqualified and consider orthogonal confirmation, preferably ApoB, when particle burden is the clinical question.
背景:多个低密度脂蛋白胆固醇(LDL-C)方程可应用于每个标准脂质面板。在治疗阈值上的分歧可能表明分类不稳定。目的:检验LDL-C方程不一致作为仅计算阈值完整性标志和正交脂质确认的触发因素。方法:我们用当日标准脂质和直接均质LDL-C分析了净化后的All of Us脂质面板,认识到直接LDL-C是一种临床参考测定方法,而不是β -定量。Friedewald、Sampson/National Institutes of Health (NIH)和Martin-Hopkins在LDL-C阈值为70、100和130 mg/dL时进行了评估;时间审计时添加55 mg/dL。将3方程不一致标志与基于甘油三酯(TG)的反射规则进行比较。使用重症监护医学信息市场IV (MIMIC-IV)进行外部压力测试。结果:方程一致性确定了高稳定性的大多数:在主要的All of Us队列中,方程一致性为86%至92%,阈值准确性为92%至95%。在时间审计中,在LDL-C阈值为55、70、100和130 mg/dL的行中,未来清洁面板显示10.2%、11.4%、9.2%和5.8%的行存在3方程不一致。所有3个方程的不一致-亚组准确性都较低。在所有4个阈值上,3方程跨式法在检测明显的目标不一致方面都优于TG≥200 mg/dL。稀疏载脂蛋白B (ApoB)分析支持ApoB作为一个独立的证人。结论:LDL-C方程不一致是一个阈值完整性标志,不能证明任何方程是错误的。当方程式在治疗目标附近不一致时,临床医生应避免将LDL-C阈值结果视为不合格,当颗粒负荷是临床问题时,应考虑正交确认,最好是ApoB。
期刊介绍:
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner.
Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.